This website has been developed by Novo Nordisk UK and contains
product and prescribing information about RYBELSUS®
intended for UK healthcare professionals. In addition, the site
contains specific information for patients prescribed
RYBELSUS® and general information for the public.
▼ This medicinal
product is subject to additional monitoring. This will allow quick
identification of new safety information.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed in the
package leaflet. You can also report side effects directly via the
Yellow Card Scheme at www.mhra.gov.uk/yellowcard↗.
By reporting side effects you can help to provide more information on
the safety of this medicine.
Please select the appropriate option below to continue: